Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis

door Sadetsky, Natalia, Hernandez, Alexandra, Wallick, Chris J., McKenna, Edward F., Surinach, Andy, Colburn, Dawn E.
Gepubliceerd in Cancer Med (2020)

A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor...

door Malhi, Vikram, Colburn, Dawn, Williams, Sarah J., Hop, Cornelis E. C. A., Dresser, Mark J., Chandra, Priya, Graham, Richard A.
Gepubliceerd in Cancer Chemother Pharmacol (2016)

Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

door Abou-Alfa, Ghassan K., Lewis, Lionel D., LoRusso, Patricia, Maitland, Michael, Chandra, Priya, Cheeti, Sravanthi, Colburn, Dawn, Williams, Sarah, Simmons, Brian, Graham, Richard A.
Gepubliceerd in Cancer Chemother Pharmacol (2017)

Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects

door Graham, Richard A, Hop, Cornelis E C A, Borin, Marie T, Lum, Bert L, Colburn, Dawn, Chang, Ilsung, Shin, Young G, Malhi, Vikram, Low, Jennifer A, Dresser, Mark J
Gepubliceerd in 2012